Kongressbeiträge 2013

  • Axtner J, Grah C, Matthes B, Happe A & Schad F. (2013a). Integrative Therapiemaßnahmen bei der Behandlung von Patienten mit fortgeschrittenem Lungenkrebs. 3. ASORS - Jahreskongress - Supportive Therapie und Rehabilitation, Berlin.
  • Axtner J, Happe A & Schad F. (2013b). Are integrative oncological therapies used by different patient populations? 6th European Congress for Integrative Medicine (ECIM), Berlin.
  • Schad F, Axtner J, Happe A, Herbstreit C & Matthes H. (2013a). Implementation of integrative oncological therapies in daily care of a certified breast cancer center. 6th European Congress for Integrative Medicine (ECIM), Berlin.
  • Schad F, Axtner J, Happe A, Kröz M, Matthes B, Grah C, Spahn G & Matthes H. (2013b). Palliative care in patients with advanced lung cancer in a network of Health service research in integrative oncology. J Clin Oncol ASCO Annual Meeting 31 (suppl. e20710).
  • Schad F, Axtner J, Happe A, Kröz M, Spahn G & Matthes H. (2013c). Health services research mirrors conventional and additional therapies in patients with pancreatic cancer in integrative oncology. 17th ECCO - 38th ESMO - 32nd ESTRO Euroepan Cancer Congress, Amsterdam.
  • Steele M, Axtner J, Happe A, Kröz M, Matthes H & Schad F. (2013). Adverse and expected drug reactions to therapy with mistletoe extracts (Viscum album L.) in cancer patients. 17th ECCO - 38th ESMO - 32nd ESTRO European Cancer Congress, Amsterdam.

 

Weitere Beiträge 2013

-